EB
Insider
Eran Broshy
DirectorEran Broshy (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales, 1 filed past the two-business-day deadline), most often in Theravance Biopharma, Inc. (TBPH). The largest single filing was $1.1M of TBPH (59,000 sh across 3 lots, as filed), executed Nov 11 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.5M
shares × price, as filed
Last traded
Nov 26 2025
Filed Dec 1 2025
Median ADV $11.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $2.5M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
3 filings
Sector per market data · by filing · past 12 months
Most traded names
TBPH
Theravance Biopharma, Inc.
TBPH · 0 buys · 3 sells
3 filings
Recent filings
TBPHSALE
Theravance Biopharma, Inc.
View filing →
$590K29,501 sh across 2 lots
Exec Nov 26 2025
Filed Dec 1 2025 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. View filing → $1.1M
59,000 sh across 3 lots
Exec Nov 11 2025
Filed Nov 13 2025 · 5:30 PM ET TBPHSALE Theravance Biopharma, Inc. View filing → $809K
45,000 sh across 3 lots
Exec Nov 11 2025
Filed Nov 14 2025 · 5:30 PM ET †